Phase-III trial of favipiravir starts in Kathmandu and Pokhara
kathmandupost.com · Wed Dec 09 19:03:05 UTC 2020
Originally made to treat the flu in Japan, the drug is currently being manufactured in Nepal itself.
Nepal Health Research Council has decided to test antiviral medicine favipiravir on Covid-19 patients admitted to hospitals in Kathmandu and Pokhara.
Read full story at source (kathmandupost.com)